Body weight reduction in women treated with tirzepatide by reproductive stage: a post hoc analysis from the SURMOUNT program

Documenti analoghi

• Early‐Onset Obesity and Tirzepatide Treatment: A Post Hoc Analysis of the SURMOUNT Clinical Trials
  di: Evgenia Gourgari, et al.
  Pubblicazione: (2025)
• Improved health‐related quality of life with tirzepatide versus semaglutide in adults with obesity or overweight from the SURMOUNT ‐5 trial
  di: Alpana P. Shukla, et al.
  Pubblicazione: (2025)
• Time to weight plateau with tirzepatide treatment in the SURMOUNT ‐1 and SURMOUNT ‐4 clinical trials
  di: Deborah B. Horn, et al.
  Pubblicazione: (2025)
• Body composition changes during weight reduction with tirzepatide in the SURMOUNT ‐1 study of adults with obesity or overweight
  di: Michelle Look, et al.
  Pubblicazione: (2025)
• Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the SURPASS clinical trial programme
  di: Brandon K. Bergman, et al.
  Pubblicazione: (2025)